Health Care Sci. 2023 Feb 23;2(1):10-24. doi: 10.1002/hcs2.36. eCollection 2023 Feb.
To further improve the diagnosis and treatment of COVID-19, the National Health Commission of People's Republic of China and the National Administration of Traditional Chinese Medicine convened a group of experts to revise the relevant content of the Diagnosis and Treatment Protocol for COVID-19 Patients (Trial Version 9) and developed the Diagnosis and Treatment Protocol for COVID-19 Patients (Trial Version 10), summarizing the etiological characteristics, epidemiological characteristics, prevention, clinical features, diagnosis, clinical classification, population with high risk of severe/critical illnesses, early warning predictors for severe/critical illnesses, differential diagnosis, case identification and reporting, treatment, nursing, control of nosocomial infection in medical institutions, and discharge criteria for inpatients.
为进一步提高新型冠状病毒肺炎（COVID-19）的诊断和治疗水平，中华人民共和国国家卫生健康委员会和国家中医药管理局组织专家对《新型冠状病毒肺炎诊疗方案（试行第九版）》相关内容进行修订，形成了《新型冠状病毒肺炎诊疗方案（试行第十版）》，总结了病原学特点、流行病学特征、预防、临床特点、诊断、临床分型、重型/危重型高危人群、重型/危重型早期预警指标、鉴别诊断、病例发现与报告、治疗、护理、医疗机构内感染防控及住院患者出院标准等内容。
